Urokinase is more common drugs, belongs to a kind of medicine extracted
from human kidney development the organization of an enzyme protein, urokinase
main effect of the drug can be used in human blood clots or blood disease, can
also be effective treatment of human heart disease or myocardial infarction,
etc., is treated by means of the human body intravenous, It's a relatively safe
Urokinase is mainly used in thrombolytic therapy for thromboembolic
diseases. Patients with acute generalized pulmonary embolism, coronary embolism
and myocardial infarction within 6-12 hours of chest pain, acute cerebrovascular
embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other
peripheral artery embolism with severe symptoms of ilio-femoral vein thrombosis.
It is also used to prevent thrombosis after artificial heart valve operation,
keep vascular intubation and drainage tube of thoracic cavity and pericardium
patency, etc. The efficacy of thrombolysis was maintained by subsequent
anticoagulation with heparin.
Urokinase is an enzymatic thrombolytic drug, which can activate plasminogen
to plasminolytic enzyme in vivo, thus hydrolyzing fibrin to dissolve freshly